These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3139113)

  • 1. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
    Thomas AE; Patterson J; Prentice HG; Brenner MK; Ganczakowski M; Hancock JF; Pattinson JK; Blacklock HA; Hopewell JP
    Bone Marrow Transplant; 1987 Apr; 1(4):347-55. PubMed ID: 3139113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
    Atkinson K; Biggs J; Noble G; Ashby M; Concannon A; Dodds A
    Bone Marrow Transplant; 1987 Dec; 2(4):385-94. PubMed ID: 3332186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
    Shaw PJ; Hugh-Jones K; Hobbs JR; Downie CJ; Barnes R
    Bone Marrow Transplant; 1986 Dec; 1(2):193-200. PubMed ID: 3332132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial cell changes due to busulfan and cyclophosphamide treatment in bone marrow transplantation.
    Stella F; Battistelli S; Marcheggiani F; De Santis M; Giardini C; Baronciani D; Manenti F; Mattioli S; Troccoli R
    Acta Cytol; 1990; 34(6):885-90. PubMed ID: 2256423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis.
    Moriyama Y; Koike T; Shibata A
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():531-6. PubMed ID: 6441037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients.
    Atkinson K; Biggs JC; Golovsky D; Concannon A; Dodds A; Downs K; Ashby M
    Bone Marrow Transplant; 1991 May; 7(5):351-4. PubMed ID: 2070143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
    Erer B; Angelucci E; Baronciani D; Tomasucci M; Giardini C; Gaziev J
    Bone Marrow Transplant; 1993; 12 Suppl 1():93-5. PubMed ID: 8374576
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation.
    Laszlo D; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Lombardini L; Longo G; Fanci R; Azzi A; De Santis R
    Haematologica; 1995; 80(5):421-5. PubMed ID: 8566882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
    Zhu K; Xu Y; Wu D; Xu X; Huang L
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):403-5. PubMed ID: 11877010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation.
    Morgan M; Dodds A; Atkinson K; Szer J; Downs K; Biggs J
    Br J Haematol; 1991 Apr; 77(4):529-34. PubMed ID: 2025579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies.
    Bandini G; Belardinelli A; Rosti G; Calori E; Motta MR; Rizzi S; Benini C; Tura S
    Bone Marrow Transplant; 1994 May; 13(5):577-81. PubMed ID: 8054910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient].
    Machaczka M; Rucińska M; Piatkowska-Jakubas B; Załuska A; Skotnicki AB
    Przegl Lek; 2001; 58(1):51-3. PubMed ID: 11450158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation.
    Leung AY; Mak R; Lie AK; Yuen KY; Cheng VC; Liang R; Kwong YL
    Bone Marrow Transplant; 2002 Mar; 29(6):509-13. PubMed ID: 11960271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Tsuboi K; Kishi K; Ohmachi K; Yasuda Y; Shimizu T; Inoue H; Matsumoto M; Hattori K; Yoshiba F; Watanabe S; Ogawa Y; Kawada H; Yabe H; Yabe M; Kato S; Hotta T
    Bone Marrow Transplant; 2003 Nov; 32(9):903-7. PubMed ID: 14561991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
    Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
    Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
    Romeiras M; Rodrigues AS; Machado A; Jorge L; Nolasco I; Abecasis M
    Bone Marrow Transplant; 1991; 7 Suppl 2():133. PubMed ID: 1878678
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
    Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
    Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide.
    Russell SJ; Vowels MR; Vale T
    Bone Marrow Transplant; 1994 May; 13(5):533-9. PubMed ID: 8054906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of hemorrhagic cystitis due to cyclophosphamide for conditioning of bone marrow transplantation].
    Mori T; Harada M; Yoshida T; Ohotake S; Shiobara S; Matsue K; Odaka K; Kondo K; Nakao S; Ueda M
    Rinsho Ketsueki; 1984 Apr; 25(4):528-34. PubMed ID: 6381790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.